Kymab

Discovers and develops human antibody therapeutics.

Launch date

2010

Employees

Market cap

Net debt

-

Enterprise valuation

$1.1b (Public information from Jan 2021)

Company register number 07027523

Babraham England (HQ)

http://www.kymab.com/

https://twitter.com/kymabltd https://www.linkedin.com/company/kymab-ltd/

Authorizing premium user...